Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$13.01 - $27.22 $356,942 - $746,807
-27,436 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$20.94 - $27.5 $519,877 - $682,742
-24,827 Reduced 47.5%
27,436 $664,000
Q4 2021

Feb 11, 2022

BUY
$16.79 - $27.09 $395,186 - $637,617
23,537 Added 81.94%
52,263 $1.22 Million
Q3 2021

Nov 12, 2021

BUY
$15.78 - $24.77 $99,193 - $155,704
6,286 Added 28.01%
28,726 $477,000
Q2 2021

Aug 12, 2021

BUY
$19.4 - $27.42 $435,335 - $615,304
22,440 New
22,440 $547,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.